Načítá se...
Association of Pituitary Adenylate Cyclase–Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease
IMPORTANCE: There is a deficit of pituitary adenylate cyclase–activating polypeptide (PACAP) in patients with neuropathologically confirmed Alzheimer dementia. However, whether this deficit is associated with the earlier stages of Alzheimer disease (AD) is unknown. This study was conducted to clarif...
Uloženo v:
| Vydáno v: | JAMA Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5924703/ https://ncbi.nlm.nih.gov/pubmed/25599520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2014.3625 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|